AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
a study on Stroke
Stroke Atrial Cardiopathy Cryptogenic stroke Ischemic stroke Apixaban Aspirin Heart Diseases
Lead Scientist at UCSF
- Karl Meisel, MD
Dr. Meisel is the director of the stroke clinic in the ambulatory care center. His interests are to provide a thorough evaluation of patients with a stroke from unclear causes (cryptogenic). He is working to use technology to achieve comprehensive care of patients after their acute stroke care. Dr. Meisel aims to use this care strategy to prevent future strokes and the related complications.